Centene Corporation (0HVB.L)
USD 59.81
(-0.08%)
USD 59.81
(-0.08%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2.7 Billion USD | 124.79% |
| 2022 | 1.2 Billion USD | -10.76% |
| 2021 | 1.34 Billion USD | -25.5% |
| 2020 | 1.8 Billion USD | 36.87% |
| 2019 | 1.32 Billion USD | 46.78% |
| 2018 | 900 Million USD | 8.7% |
| 2017 | 828 Million USD | 47.33% |
| 2016 | 562 Million USD | 58.31% |
| 2015 | 355 Million USD | 32.46% |
| 2014 | 268 Million USD | 66.46% |
| 2013 | 161 Million USD | 80.9% |
| 2012 | 89 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 1.16 Billion USD | 2484.44% |
| 2024 Q2 | 1.14 Billion USD | -1.46% |
| 2024 Q3 | 713 Million USD | -37.78% |
| 2023 Q3 | 469 Million USD | -55.67% |
| 2023 Q1 | 1.13 Billion USD | 630.52% |
| 2023 FY | 2.7 Billion USD | 124.79% |
| 2023 Q4 | 45 Million USD | -90.41% |
| 2023 Q2 | 1.05 Billion USD | -6.37% |
| 2022 Q2 | -172 Million USD | -120.26% |
| 2022 Q1 | 849 Million USD | 41.74% |
| 2022 Q3 | 738 Million USD | 529.07% |
| 2022 FY | 1.2 Billion USD | -10.76% |
| 2022 Q4 | -213 Million USD | -128.86% |
| 2021 Q3 | 584 Million USD | 209.16% |
| 2021 Q4 | 599 Million USD | 2.57% |
| 2021 FY | 1.34 Billion USD | -25.5% |
| 2021 Q1 | 699 Million USD | 5925.0% |
| 2021 Q2 | -535 Million USD | -176.54% |
| 2020 Q2 | 1.2 Billion USD | 2521.74% |
| 2020 Q1 | 46 Million USD | -77.99% |
| 2020 Q4 | -12 Million USD | -102.11% |
| 2020 Q3 | 568 Million USD | -52.9% |
| 2020 FY | 1.8 Billion USD | 36.87% |
| 2019 Q2 | 495 Million USD | -5.17% |
| 2019 Q3 | 95 Million USD | -80.81% |
| 2019 FY | 1.32 Billion USD | 46.78% |
| 2019 Q1 | 522 Million USD | 116.6% |
| 2019 Q4 | 209 Million USD | 120.0% |
| 2018 Q2 | 300 Million USD | -11.76% |
| 2018 Q1 | 340 Million USD | 47.83% |
| 2018 Q4 | 241 Million USD | 1168.42% |
| 2018 FY | 900 Million USD | 8.7% |
| 2018 Q3 | 19 Million USD | -93.67% |
| 2017 Q4 | 230 Million USD | 12.2% |
| 2017 Q3 | 205 Million USD | -19.29% |
| 2017 Q2 | 254 Million USD | 82.73% |
| 2017 Q1 | 139 Million USD | -45.49% |
| 2017 FY | 828 Million USD | 47.33% |
| 2016 Q4 | 255 Million USD | 72.3% |
| 2016 FY | 562 Million USD | 58.31% |
| 2016 Q3 | 148 Million USD | -13.45% |
| 2016 Q2 | 171 Million USD | 1240.0% |
| 2016 Q1 | -15 Million USD | -113.39% |
| 2015 Q2 | 88 Million USD | 37.5% |
| 2015 FY | 355 Million USD | 32.46% |
| 2015 Q1 | 64 Million USD | -39.62% |
| 2015 Q4 | 112 Million USD | 21.74% |
| 2015 Q3 | 92 Million USD | 4.55% |
| 2014 Q2 | 47 Million USD | 38.24% |
| 2014 Q4 | 106 Million USD | 30.86% |
| 2014 Q3 | 81 Million USD | 72.34% |
| 2014 FY | 268 Million USD | 66.46% |
| 2014 Q1 | 34 Million USD | -28.79% |
| 2013 Q1 | 22.63 Million USD | -76.47% |
| 2013 FY | 161 Million USD | 80.9% |
| 2013 Q3 | 50.32 Million USD | 24.91% |
| 2013 Q4 | 47.74 Million USD | -5.12% |
| 2013 Q2 | 40.28 Million USD | 77.96% |
| 2012 FY | 89 Million USD | 0.0% |
| 2012 Q4 | 96.2 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 2073.92% |
| Accuray Incorporated | -15.54 Million USD | 17481.795% |
| Align Technology, Inc. | 445.05 Million USD | -507.119% |
| Elevance Health Inc. | 5.98 Billion USD | 54.869% |
| AxoGen, Inc. | -21.71 Million USD | 12542.439% |
| Boston Scientific Corporation | 1.59 Billion USD | -69.617% |
| CVS Health Corporation | 8.34 Billion USD | 67.617% |
| Cardinal Health, Inc. | 852 Million USD | -217.136% |
| DaVita Inc. | 691.53 Million USD | -290.725% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 48.455% |
| Hologic, Inc. | 789.5 Million USD | -242.242% |
| Humana Inc. | 2.48 Billion USD | -8.558% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | -219.747% |
| Laboratory Corporation of America Holdings | 418 Million USD | -546.411% |
| Masimo Corporation | 81.5 Million USD | -3215.337% |
| McKesson Corporation | 3 Billion USD | 9.993% |
| Patterson Companies, Inc. | 185.93 Million USD | -1353.227% |
| Quest Diagnostics Incorporated | 854 Million USD | -216.393% |
| ResMed Inc. | 1.02 Billion USD | -164.655% |
| Henry Schein, Inc. | 416 Million USD | -549.519% |
| Teladoc Health, Inc. | -220.36 Million USD | 1326.131% |
| Universal Health Services, Inc. | 717.79 Million USD | -276.431% |
| Veeva Systems Inc. | 525.7 Million USD | -413.976% |
| Baxter International Inc. | 2.65 Billion USD | -1.732% |
| Becton, Dickinson and Company | 1.48 Billion USD | -82.075% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | -50.278% |
| Danaher Corporation | 4.2 Billion USD | 35.667% |
| Stryker Corporation | 3.16 Billion USD | 14.629% |
| Medtronic plc | 3.67 Billion USD | 26.496% |